v3.20.1

Consolidated companies as of December 31, 2019 (Details) - entity | 12 Months Ended
--- | ---
Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Belgium |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Number of new legal entities incorporated |  | 2 |
BioFocus DPI AG | Switzerland |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Fidelta d.o.o. | Croatia |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Galapagos Biopharma BV | The Netherlands |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% |  |
Changes in voting rights | 100.00% |  |
Galapagos Biopharma BV | Belgium |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% |  |
Changes in voting rights | 100.00% |  |
Galapagos B.V | The Netherlands |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Galapagos Biopharma Spain S.L.U | Spain |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% |  |
Changes in voting rights | 100.00% |  |
Galapagos Biopharma Italy S.r.l. | Italy |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% |  |
Changes in voting rights | 100.00% |  |
Galapagos Biopharma Germany GmbH | Germany |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% |  |
Changes in voting rights | 100.00% |  |
Galapagos Biotech Ltd. (formerly Inpharmatica Ltd.) | United Kingdom |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Galapagos GmbH | Switzerland |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Galapagos Real Estate 1 BV | Belgium |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% |
Galapagos Real Estate 2 BV | Belgium |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% |
Galapagos Real Estate B.V. | The Netherlands |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% |  |
Changes in voting rights | 100.00% |  |
Galapagos SASU (France) | France |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Galapagos, Inc. (formerly Biofocus, Inc.) | United States |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%
Xenometrix, Inc. | United States |  |  |
Consolidated companies as of December 31, 2019 |  |  |
Percentage of voting rights held directly or indirectly through subsidiaries | 100.00% | 100.00% | 100.00%

X
- Definition The changes in ownership interests in subsidiaries. + References No definition available. + Details
Name: | glpg_ChangeInOwnershipInterest
Namespace Prefix: | glpg_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents new legal entities the company incorporated. + References No definition available. + Details
Name: | glpg_NewLegalEntitiesIncorporated
Namespace Prefix: | glpg_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph 19B -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_ProportionOfVotingPowerHeldInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_BE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_BiofocusDpiAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_CH
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_FideltaD.o.o.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_HR
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosBiopharmaB.v.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_NL
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosB.vMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosBiopharmaS.l.uMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_ES
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosBiopharmaS.r.lMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_IT
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosBiopharmaGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_DE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosBiotechLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_GB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosRealEstateOneBvMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosRealEstateTwoBvMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosRealEstateB.v.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosSasuMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_FR
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_GalapagosInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=glpg_XenometrixInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |